Klaricid 250mg Tablets Ref.[2663] Active ingredients: Clarithromycin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2011  Publisher: Abbott Laboratories Limited Abbott House Vanwall Business Park Vanwall Road Maidenhead Berkshire SL6 4XE UK

Product name and form

Klaricid or Clarithromycin 250 mg Tablets.

Pharmaceutical Form

A yellow, ovaloid film-coated tablet containing 250 mg of clarithromycin.

Qualitative and quantitative composition

250 mg/tablet.

Active: Clarithromycin.

Active Ingredient Description
Clarithromycin

Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.
List of Excipients

Croscarmellose sodium
Starch pregelatinised
Cellulose microcrystalline
Silica gel
Povidone
Stearic acid
Magnesium stearate
Talc
Hypromellose
Hydroxypropylcellulose
Propylene glycol
Sorbitan monooleate
Titanium dioxide
Sorbic acid
Vanillin
Quinoline yellow E104

Pack sizes and marketing

2/14/56 tablets in a blister original pack. The blisters are packaged in a carton with a pack insert.

Marketing authorization holder

Abbott Laboratories Limited
Abbott House
Vanwall Business Park
Vanwall Road
Maidenhead
Berkshire
SL6 4XE
UK

Marketing authorization dates and numbers

PL 0037/0211

09/04/91

Drugs

Drug Countries
KLARICID Brazil, Ecuador, Japan, Mexico, United Kingdom
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈